Trials / Conditions / Crigler-Najjar Syndrome

Crigler-Najjar Syndrome

11 registered clinical trials studyying Crigler-Najjar Syndrome — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome NCT06518005	Genethon	Phase 2
Completed	Baby Detect : Genomic Newborn Screening NCT05687474	Centre Hospitalier Universitaire de Liege	—
Terminated	HepaStem Long-Term Safety Registry NCT03343756	Cellaion SA	—
Recruiting	Gene Therapy for Severe Crigler Najjar Syndrome NCT03466463	Genethon	N/A
Terminated	Gene Transfer Clinical Study in Crigler-Najjar Syndrome NCT03223194	Audentes Therapeutics	Phase 1
Completed	Clinical Assessment Study in Crigler-Najjar Syndrome NCT03078881	Audentes Therapeutics	—
Unknown	New Phototherapy Device to Treat Patients With Crigler-Najjar Disease NCT02356978	Assistance Publique - Hôpitaux de Paris	N/A
Completed	Immunity Against AAV in Crigler Najjar Patient NCT02302690	Genethon	—
Completed	Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001) NCT02051049	Cellaion SA	—
Completed	Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN) NCT01765283	Cellaion SA	Phase 1 / Phase 2
Completed	Orlistat Treatment of Crigler-Najjar Disease NCT00461799	University Medical Center Groningen	N/A